Asia Medical and Agricultural Laboratory and Research Center Public Company (AMARC) Fair Value & Analysis
Technology · TH · Market cap 1.4B THB
Fair value as of: Jul 18, 2026
From 26 valuation models · updated 23 days ago
Fair value updated Jul 18, 2026, revised from 6.21 THB to 6.32 THB (+1.8%) since Jul 14, 2026. Share price −21.1% over the past month.
A strong business, screening 116% undervalued on our models.
What matters now
- The rarer combination: high quality (80/100) AND below fair value. That earns a closer look rather than a quick verdict.
- The price is below even our cautious bear case (4.75 THB). The market is more pessimistic than our downside scenario.
- A fairly wide model range (4.75 THB to 12.30 THB) leaves room in how you read the outcome.
Price vs Fair Value (4 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 18, 2026.
How to read this chart
46‑month range 1.01 THB – 4.92 THB · fair‑value band 4.75 THB – 12.30 THB · the 2.92 THB price screens below the 6.32 THB fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 18, 2026.
Analysis
Asia Medical and Agricultural Laboratory and Research Center Public Company (AMARC) currently trades at 2.92 THB, while our model-based Fair Value estimate is 6.32 THB, implying the stock looks roughly 116.4% undervalued today. The Quality Score stands at 80/100 (high quality), in the Technology sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.
Over the trailing twelve months, Asia Medical and Agricultural Laboratory and Research Center Public Company generated revenue of 497M THB at a net margin of 31.8%. Revenue grew 2.1% year over year. It earns a return on equity of 27.4%. The balance sheet holds a net cash position of 15.3M THB. Fundamentals as of Jul 18, 2026
Our scenario range runs from 4.75 THB (bear case) to 12.30 THB (bull case); at 2.92 THB, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 47% below its 52-week high and 57% above its 52-week low, currently below its 200-day average. For context, the median of 10 Technology peers we cover trades at -45% fair-value upside, at 116%, AMARC screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 26 models by family
Widest divergence: Growth Earnings (9.46 THB) versus Asset-Based (0.9900 THB). Highest evidence: Growth DCF (80).
Notify me when AMARC reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 18, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 78 · Market factors (momentum, volatility) 45
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Asia Medical and Agricultural Laboratory and Research Center Public Company Limited provides scientific services for the agriculture, food, pharmaceutical, and environment industries in Thailand.
Full company description
Asia Medical and Agricultural Laboratory and Research Center Public Company Limited provides scientific services for the agriculture, food, pharmaceutical, and environment industries in Thailand. The company offers one stop and customized services, and quality, contaminants, additive services for meat and meat products, fats and oils, pet food, feedstuffs and feed raw materials, aquaculture aquatic animals and aquatic animal products, crops, foods, beverages, nutrition label, product shelf life, food contact materials, water ice, potable water, and utility water. It also provides fertilizer, hazardous substances, and research and development services for fertilizer, hazardous substance used in agriculture, soil, and water, as well as efficacy and residue testing of pesticide; testing and analyzing the quality of modern drugs, cannabis, hemp, herbs, and cosmetics; and checks the quality of water for consumption, production process water, and wastewater, as well as soil and air. In addition, the company offers calibration of instruments and equipment, including electrical and temperature, chemical, and mechanical metrology, as well as medical devices comprising electrocardiograph, non-invasive blood pressure monitor, patient monitor, oximeter pulse, and electrical safety analyzer; and inspection and certification for farming and agriculture, food processing and manufacturing, and environment. Further, it provides consultation and training services for laboratory quality management system, food sanitation, good food production standards, reporting calibration results of instrument and equipment, and standard systems. The company was founded in 2004 and is headquartered in Bangkok, Thailand. Asia Medical and Agricultural Laboratory and Research Center Public Company Limited is a subsidiary of Ladprao General Hospital Public Company Limited.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Asia Medical and Agricultural Laboratory and Research Center Public Company reported revenue of 491M THB in FY2025 versus 246M THB in FY2021, a compound +18.9%/yr. Reported net income was 159M THB in FY2025, compounding +58.9%/yr from FY2021.
Watch AMARC: get an alert when its fair value changes →
Peer Group
Scientific & Technical Instruments · 161 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Scientific & Technical Instruments median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Insider activity: 40/100
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Scientific & Technical Instruments stocks, each showing price versus our Fair Value estimate (as of Jul 18, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Keysight Technologies, Inc KEYS | $315.90 | $84.16 | -73% |
| Garmin Ltd GRMN | $241.76 | $146.67 | -39% |
| Teledyne Technologies Incorporated TDY | $635.52 | $367.58 | -42% |
| Chroma ATE Inc 2360 | 1,905 TWD | 286.15 TWD | -85% |
| Hexagon AB HEXAB | kr 80.10 | kr 52.93 | -34% |
| MKS Inc MKSI | $324.69 | $77.46 | -76% |
| AVIC Chengdu Aircraft Company 302132 | ¥52.91 | ¥34.47 | -35% |
| Fortive Corporation FTV | $61.78 | $33.84 | -45% |
| Trimble Inc TRMB | $52.72 | $24.47 | -54% |
| Cognex Corporation CGNX | $64.07 | $13.75 | -79% |
Compare Asia Medical and Agricultural Laboratory and Research Center Public Company with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Technology stocks →
Frequently asked questions
Is Asia Medical and Agricultural Laboratory and Research Center Public Company (AMARC) overvalued or undervalued?
What is the fair value of AMARC?
What is the quality score of AMARC?
What is the revenue of Asia Medical and Agricultural Laboratory and Research Center Public Company (AMARC)?
What is the net profit margin of AMARC?
Does Asia Medical and Agricultural Laboratory and Research Center Public Company pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Asia Medical and Agricultural Laboratory and Research Center Public Company and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.